By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



343 Sansome Street
Suite 505
San Francisco  California  94104-5622  U.S.A.
Phone: n/a Fax: n/a


Company News
Shire plc Boosts Eye Business With $160 Million SARcode Buy 3/25/2013 6:45:16 AM
First Subject Enrolled in OPUS-2, SARcode's Second Pivotal Study of Lifitegrast Ophthalmic Solution 1/8/2013 9:54:31 AM
SARcode Announces Positive Topline Results From Phase 3 Dry Eye Study of Lifitegrast 10/23/2012 10:13:11 AM
SARcode Release: Last Patient Enrolled in Pivotal Phase 3 Dry Eye Study (OPUS-1) of SAR 1118 Ophthalmic Solution 3/5/2012 11:22:03 AM
First Patient Enrolled in SARcode's Pivotal Dry Eye Study of SAR 1118 Ophthalmic Solution 9/14/2011 11:36:21 AM
SARcode Pulls in $44 Million Series B Financing 7/18/2011 6:38:54 AM
SARcode's SAR 1118 Demonstrates Encouraging Results in Phase 2 Study of Dry Eye Disease 5/4/2011 7:34:28 AM
SARcode to Present Phase 2 Clinical Data for Dry Eye Candidate at the ARVO2011 Annual Meeting 3/24/2011 7:15:09 AM
Todd A. Creech Named Chief Financial Officer and Vice President of Business Development for SARcode 2/14/2011 7:01:19 AM
Quinton Oswald Named Chief Executive Officer of SARcode 9/14/2010 8:23:20 AM